There are so many green news today that include Codexis, GlycosBio, Elevance and DuPont. We’ll first focus on DuPont as it has been awhile since the blog last heard of any biotech-based chemical news from them.
DuPont’s joint venture, DuPont Tate & Lyle Bio Products, LLC, announced today that it is expanding production of bio-based 1,3 propanediol (Bio-PDO™) by 35% at its Loudon, Tennessee, facility, starting in June, and expected to be complete by second quarter 2011. Last I recall, DuPont’s current bio-PDO capacity is around 45,000 tonnes/year.
The expansion is being driven by strong demand, according to DuPont. Their corn-based bio-PDO is used as an ingredient ranging from cosmetics and personal care formulations to fluids and polymers including DuPont’s Sorona® renewably sourced polymer. The Bio-PDO™ is sold under the Zemea® and Susterra® brands.
“We had record sales last year and are already anticipating the need for additional capacity after just three years of operation,” said Steve Mirshak, president – DuPont Tate & Lyle Bio Products. “This expansion is proof that cutting-edge industrial biotechnology can deliver products that meet the needs of industry and consumers while contributing to a smaller environmental footprint.”
Also as far as I know, the DuPont venture is the only one producing bio-PDO right now (let me know otherwise) although I did remember France-based METabolic Explorer developing their glycerine-based PDO.
METabolic Explorer has already started operating its bio-PDO pilot plant in Clermont Ferrand, France, last year December. The company estimates the global PDO market to reach EUR 1.3bn by 2020.
[Photo of DuPont Tate & Lyle BioProducts' facility in Tenn.]